Thursday, November 30, 2023 10:40:59 AM
Recent TTOO News
- T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor • GlobeNewswire Inc. • 12/18/2024 02:00:00 PM
- T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally • GlobeNewswire Inc. • 12/17/2024 02:00:00 PM
- T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. • GlobeNewswire Inc. • 12/16/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2024 02:00:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/09/2024 02:02:59 PM
- T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens • GlobeNewswire Inc. • 12/09/2024 02:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/20/2024 09:45:27 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/20/2024 09:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2024 02:54:00 PM
- T2 Biosystems Announces Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/14/2024 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 08:49:19 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2024 08:38:45 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/08/2024 10:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 02:30:28 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/07/2024 02:02:19 AM
- T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 • GlobeNewswire Inc. • 11/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:59:59 PM
- T2 Biosystems to Host Business Update Call on October 10, 2024 • GlobeNewswire Inc. • 10/08/2024 08:05:00 PM
- T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform • GlobeNewswire Inc. • 10/08/2024 01:00:00 PM
- T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens • GlobeNewswire Inc. • 10/07/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 01:00:32 PM
- T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/07/2024 01:00:00 PM
- T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture • GlobeNewswire Inc. • 09/23/2024 01:00:00 PM
- T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union • GlobeNewswire Inc. • 09/20/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:59:59 PM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM